Publications by authors named "Markus Bangerter"

Claim this Profile
[
[Chemotherapy is better than its reputation: important developments within the last decades].
Bernhard Heinrich, Olaf Brudler, Markus Bangerter

MMW Fortschr Med· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial.
Clemens Giessen, Ludwig Fischer von Weikersthal, Axel Hinke, Sebastian Stintzing, Frank Kullmann, Markus Bangerter

BMC Cancer· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytomorphologic pitfall of primary malignant melanoma of the parotid gland: a case report.
Markus Bangerter

Acta Cytol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Markus Bangerter, Roland M Schmid

MMW Fortschr Med· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open or closed nuclear membrane? A question to help distinguish malignant lymphoma from carcinoma and sarcoma.
Markus Bangerter, Olaf Brudler, Bernhard Heinrich, Ingrid Schrembs, Martin Griesshammer

Acta Cytol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fine needle aspiration cytology and flow cytometry in the diagnosis and subclassification of non-Hodgkin's lymphoma based on the World Health Organization classification.
Markus Bangerter, Olaf Brudler, Bernhard Heinrich, Martin Griesshamnuer

Acta Cytol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia.
Alexander Kröber, Johannes Bloehdorn, Sebastian Hafner, Andreas Bühler, Till Seiler, Markus Bangerter

J Clin Oncol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3'-[18F]fluoro-3'-deoxythymidine ([18F]-FLT) as positron emission tomography tracer for imaging proliferation in a murine B-Cell lymphoma model and in the human disease.
Martin Wagner, Ulrike Seitz, Andreas Buck, Bernd Neumaier, Stefan Schultheiss, Markus Bangerter

Cancer Res· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis